1
/
of
1
Elabscience
SKU:PKSH030735
Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active)
Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active)
Regular price
$732.00 USD
Regular price
Sale price
$732.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active), a cutting-edge product meticulously engineered to revolutionize the field of biotechnology. This protein, derived from human sources, boasts an exceptional level of purity and activity, making it an invaluable tool for researchers and scientists alike.
With its high-quality His Tag, this recombinant protein offers enhanced stability and ease of purification, ensuring optimal performance in a wide range of applications. Its active nature further amplifies its utility, enabling precise and reliable results in various experimental settings.
The Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) is meticulously manufactured using state-of-the-art techniques, guaranteeing batch-to-batch consistency and reproducibility. Its exceptional purity is achieved through a rigorous purification process, resulting in a product free from contaminants and impurities.
This protein's versatility is unparalleled, as it can be employed in numerous research areas, including but not limited to immunology, cancer biology, and drug discovery. Its ability to interact with IL17BR and IL17RB receptors opens up new avenues for investigating their roles in cellular signaling pathways and disease progression.
Furthermore, the Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) is accompanied by comprehensive documentation, including a Certificate of Analysis, ensuring transparency and facilitating seamless integration into experimental protocols. Its long shelf life and stability guarantee prolonged usability, making it a cost-effective investment for laboratories and research institutions.
In summary, the Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) represents a breakthrough in biotechnological advancements, offering researchers an unparalleled tool to unravel the intricacies of cellular processes and disease mechanisms. With its exceptional purity, activity, and versatility, this protein is poised to revolutionize the scientific landscape and drive groundbreaking discoveries.
With its high-quality His Tag, this recombinant protein offers enhanced stability and ease of purification, ensuring optimal performance in a wide range of applications. Its active nature further amplifies its utility, enabling precise and reliable results in various experimental settings.
The Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) is meticulously manufactured using state-of-the-art techniques, guaranteeing batch-to-batch consistency and reproducibility. Its exceptional purity is achieved through a rigorous purification process, resulting in a product free from contaminants and impurities.
This protein's versatility is unparalleled, as it can be employed in numerous research areas, including but not limited to immunology, cancer biology, and drug discovery. Its ability to interact with IL17BR and IL17RB receptors opens up new avenues for investigating their roles in cellular signaling pathways and disease progression.
Furthermore, the Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) is accompanied by comprehensive documentation, including a Certificate of Analysis, ensuring transparency and facilitating seamless integration into experimental protocols. Its long shelf life and stability guarantee prolonged usability, making it a cost-effective investment for laboratories and research institutions.
In summary, the Recombinant Human IL17BR/IL17RB Protein (His Tag)(Active) represents a breakthrough in biotechnological advancements, offering researchers an unparalleled tool to unravel the intricacies of cellular processes and disease mechanisms. With its exceptional purity, activity, and versatility, this protein is poised to revolutionize the scientific landscape and drive groundbreaking discoveries.
Share
